SAFETY AND TOLERABILITY OF CARIPRAZINE IN THE LONG-TERM TREATMENT OF SCHIZOPHRENIA

被引：1
|
作者：
Durgam, Suresh [1 ]
Cutler, Andrew J. [2 ]
Wang, Yao [1 ]
Migliore, Raffaele [1 ]
Lu, Kaifeng [1 ]
Laszlovszky, Istvan [3 ]
Nagy, Krisztian [3 ]
机构：
[1] Forest Res Inst, Jersey City, NJ USA
[2] Florida Clin Res Ctr LLC, Maitland, FL USA
[3] Gedeon Richter Plc, Budapest, Hungary
来源：
SCHIZOPHRENIA RESEARCH | 2014年 / 153卷
关键词：
D O I：
10.1016/S0920-9964(14)70777-7
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
M227
引用
收藏
页码：S272 / S272
页数：1
相关论文
共 50 条
  • [1] Safety and tolerability of cariprazine in long-term treatment of schizophrenia: integrated summary of safety data
    Nasrallah, H. A.
    Cutler, A. J.
    Wang, Y.
    Lu, K.
    Nagy, K.
    Laszlovszky, I.
    Durgam, S.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S536 - S536
  • [2] Safety and tolerability of cariprazine in long-term treatment of schizophrenia: Integrated summary of safety data
    Durgam, S.
    Nasrallah, H. A.
    Nasrallah, Henry A.
    Cutler, A.
    Wang, Y.
    Lu, K.
    Nagy, K.
    Laszlovszky, I.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 68 - 68
  • [3] The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis
    Nasrallah, Henry A.
    Earley, Willie
    Cutler, Andrew J.
    Wang, Yao
    Lu, Kaifeng
    Laszlovszky, Istvan
    Nemeth, Gyorgy
    Durgam, Suresh
    [J]. BMC PSYCHIATRY, 2017, 17
  • [4] The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis
    Henry A. Nasrallah
    Willie Earley
    Andrew J. Cutler
    Yao Wang
    Kaifeng Lu
    István Laszlovszky
    György Németh
    Suresh Durgam
    [J]. BMC Psychiatry, 17
  • [5] Long-term safety and tolerability of cariprazine as adjunctive therapy in major depressive disorder
    Vieta, Eduard
    Earley, Willie R.
    Burgess, Maria V.
    Durgam, Suresh
    Chen, Changzheng
    Zhong, Yan
    Barabassy, Agota
    Nemeth, Gyorgy
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2019, 34 (02) : 76 - 83
  • [6] LONG-TERM SAFETY AND TOLERABILITY OF BREXPIPRAZOLE IN PATIENTS WITH SCHIZOPHRENIA
    Hakala, Mika
    Gislum, Mette
    Skuban, Aleksandar
    Meehan, Stine
    [J]. SCHIZOPHRENIA BULLETIN, 2018, 44 : S94 - S95
  • [7] TOLERABILITY OF REMOXIPRIDE IN THE LONG-TERM TREATMENT OF SCHIZOPHRENIA - AN OVERVIEW
    HOLM, AC
    EDSMAN, I
    LUNDBERG, T
    ODLIND, B
    [J]. DRUG SAFETY, 1993, 8 (06) : 445 - 456
  • [8] Long-term safety and tolerability of aripiprazole lauroxil in patients with schizophrenia
    Nasrallah, Henry A.
    Aquila, Ralph
    Du, Yangchun
    Stanford, Arielle D.
    Claxton, Amy
    Weiden, Peter J.
    [J]. CNS SPECTRUMS, 2019, 24 (04) : 395 - 403
  • [9] Long-term safety and tolerability of paliperidone palmitate in patients with schizophrenia
    Gopal, S.
    Vijapurkar, U.
    Lim, P.
    Morozova, M.
    Eerdekens, M.
    Hough, D.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 218 - 219
  • [10] Long-term safety and tolerability of open-label cariprazine in patients with bipolar I disorder
    Ketter, T. A.
    Sachs, G. S.
    Lu, K.
    Ruth, A.
    Laszlovszky, I.
    Nagy, K.
    Starace, A.
    Durgam, S.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S377 - S377
12345